Skip to main content
Article
Guillain-Barré Syndrome after Gardasil Vaccination: Data From Vaccine Adverse Event Reporting System 2006-2009.
Vaccine
  • Nizar Souayah
  • P A Michas-Martin
  • Abu Nasar
  • Nataliya Krivitskaya
  • Hussam A. Yacoub, MD, Lehigh Valley Health Network
  • Hafiz Khan
  • Adnan I Qureshi
Publication/Presentation Date
1-29-2011
Abstract
Using data from Vaccine Adverse Event Reporting System, we identified 69 reports of Guillain-Barré Syndrome (GBS) after Gardasil vaccination that occurred in the United States between 2006 and 2009. The onset of symptoms was within 6 weeks after vaccination in 70% of the patients in whom the date of vaccination was known. The estimated weekly reporting rate of post-Gardasil GBS within the first 6 weeks (6.6 per 10,000,000) was higher than that of the general population, and higher than post-Menactra and post-influenza vaccinations. Further prospective active surveillance for accurate ascertainment and identification of high-risk groups of GBS after Gardasil vaccination is warranted.
PubMedID
20869467
Document Type
Article
Citation Information

Souayah, N., Michas-Martin, P. A., Nasar, A., Krivitskaya, N., Yacoub, H. A., Khan, H., & Qureshi, A. I. (2011). Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine, 29(5), 886-889. doi:10.1016/j.vaccine.2010.09.020